razoxane has been researched along with Leukopenia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (92.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV | 1 |
| Baker, SR; Bricker, LJ; Natale, RB; Wheeler, RH | 1 |
| Cullinan, S; Everson, L; Gerstner, J; Krook, J; Laurie, J; McCormack, G; Schutt, A; Scott, M; Shreck, R; Windschitl, H | 1 |
| Blessing, JA; Conroy, JF; Homesley, HD; Kessinger, A | 1 |
| Blessing, JA; Conroy, JF; Hatch, K; Lewis, GC; Mangan, C; Wilbanks, G | 1 |
| Belt, R; Haas, C; Hoogstraten, B; Liesmann, J | 1 |
| Kaplan, BH; Lanham, R; Vogl, SE | 1 |
| Begg, CB; Glick, JH; O'Connell, MJ; Oken, MM; Silverstein, MN | 1 |
| Olweny, CL; Otim, D; Sikyewunda, W | 1 |
| Hassenstein, E; Renner, K | 1 |
| Bush, H; Hellmann, K; James, SE; Spittle, MF | 1 |
| Hellmann, K; James, SE; Jones, S; Macdonald, E; Newton, KA; Ryall, RD | 1 |
| Bellet, RE; Muggia, FM; Penta, JS; Rozencweig, M; Von Hoff, DD; Wasserman, TH | 1 |
4 trial(s) available for razoxane and Leukopenia
| Article | Year |
|---|---|
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nausea; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Stomatitis; Thrombocytopenia; Triazines; Vomiting | 1983 |
Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Leukopenia; Nausea; Piperazines; Razoxane; Rectal Neoplasms; Thrombocytopenia; Triazines | 1980 |
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Myeloproliferative Disorders; Piperazines; Probability; Prognosis; Razoxane; Thrombocytopenia | 1980 |
Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Esophagitis; Humans; Leukopenia; Piperazines; Radiation Injuries; Radiotherapy, High-Energy; Razoxane | 1979 |
10 other study(ies) available for razoxane and Leukopenia
| Article | Year |
|---|---|
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia | 2005 |
Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Leukopenia; Male; Middle Aged; Piperazines; Razoxane | 1984 |
Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperazines; Razoxane; Thrombocytopenia | 1984 |
ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
Topics: Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukopenia; Piperazines; Razoxane; Thrombocytopenia; Uterine Cervical Neoplasms | 1984 |
Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancy.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Granulocytes; Humans; Infusions, Parenteral; Leukocyte Count; Leukopenia; Myeloproliferative Disorders; Neoplasms; Piperazines; Platelet Count; Razoxane | 1981 |
Further experience with rezoxane (ICRF 159; -- NSC --129943) in treating Kaposi's sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Leukopenia; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous; Sarcoma, Kaposi; Time Factors | 1980 |
[Study on hematological toxicity in irradiation and ICRF 159 combination treatment during experimentation on animals with particular consideration of long-term effects (author's transl)].
Topics: Animals; Blood Cell Count; Blood Platelets; Female; Hematopoiesis; Leukocyte Count; Leukopenia; Mice; Piperazines; Razoxane; Specific Pathogen-Free Organisms; Thrombocytopenia; Time Factors | 1978 |
Comparison of radiotherapy with and without razoxane (ICRF 159) in the treatment of soft tissue sarcomas.
Topics: Adult; Aged; Female; Humans; Leukopenia; Male; Middle Aged; Piperazines; Radiotherapy, High-Energy; Razoxane; Recurrence; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms | 1978 |
ICRF-159: current status and clinical prospects.
Topics: Alopecia; Animals; Colonic Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphoma; Melanoma; Mice; Nausea; Neoplasms, Experimental; Piperazines; Razoxane; Rectal Neoplasms; Sarcoma | 1977 |
Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Agents; Deoxyguanosine; Dianhydrogalactitol; Drug Evaluation; Humans; Leukopenia; Pancreatic Neoplasms; Piperazines; Razoxane; Sugar Alcohols; Thionucleosides; Thrombocytopenia; Triazines | 1985 |